Richard Sylvester
Papers
1
Total Citations
156
H-Index
1
About
Richard Sylvester is a leading biostatistician and methodologist in urological oncology, best known for his transformative contributions to evidence-based clinical research in bladder cancer and upper tract urothelial carcinoma. His work has fundamentally shaped how the field designs and interprets clinical trials, particularly through his leadership in the European Organisation for Research and Treatment of Cancer (EORTC) Genito-Urinary Group. Sylvester’s most cited paper, a 2017 systematic review for the European Association of Urology Guidelines, compared laparoscopic nephroureterectomy to open surgery for upper tract urothelial carcinoma, drawing on over 150 citations to guide surgical practice. He is widely recognized for developing the EORTC risk tables for non-muscle-invasive bladder cancer, a tool used globally to predict recurrence and progression, and for his pivotal role in establishing the standard of care for intravesical therapy. With a career spanning decades, Sylvester has authored hundreds of papers, many accumulating thousands of citations, and has received numerous awards for his statistical rigor and dedication to improving patient outcomes. His work remains essential reading for any researcher seeking to understand the design of urological trials or the evidence behind current treatment guidelines.
Research Focus
Key Achievements
Top Papers
- 1